Lachnum exopolysaccharides carboxymethylation derivative and application thereof in preparation of renal failure-resistant medicines thereof

The invention discloses a lachnum exopolysaccharides carboxymethylation derivative and an application thereof in preparation of chronic renal failure-resistant medicines. The lachnum exopolysaccharides carboxymethylation derivative is characterized in that lachnum exopolysaccharides with the strain collection number of CCTCC No: M 2011196 are subjected to chloroacetic acid carboxymethylation modification to obtain the lachnum exopolysaccharides carboxymethylation derivative, and the lachnum exopolysaccharides carboxymethylation derivative in an effective dose and medical auxiliary materials are prepared into tablets and capsules for clinical use according to a conventional preparation method in pharmaceutics due to the effect of obviously resisting chronic renal failure. The pharmacodynamic experiment proves that the exopolysaccharides and carboxymethylation derivative has an obvious effect of resisting chronic renal failure and does not have a toxic or side effect, and the preparation method is simple and economic.